無細胞真皮基質市場：依原料、應用、移植部位及區域分類

Acellular Dermal Matrices Market, By Origin, By Application, By Place of Setting, and By Region

出版日期: 2026年04月29日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，無細胞真皮基質市場規模將達到 124.1 億美元，到 2033 年將達到 279.5 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 12.3%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	124.1億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	12.30%	2033年市場規模預測：	279.5億美元

無細胞真皮基質是透過去細胞過程製備的。此過程去除細胞，保留細胞外基質。將細胞外基質移植到目標部位，可作為供體細胞的支架。供體細胞促進血管再生，最終形成新的組織。

市場動態：

隨著女性乳癌發生率的不斷上升，切除術率也預計將隨之增加。因此，無細胞真皮基質市場在預測期內有望成長。例如，根據世界衛生組織（WHO）的數據，2019年印度約有209萬例乳癌病例和62.7萬例死亡病例。乳癌是印度最常見的癌症類型，約佔女性所有癌症病例的14%。在印度，乳癌的發生率預計從30歲出頭開始上升，並在50至64歲之間達到高峰。

隨著各國無細胞真皮基質產品的供應日益充足，預計基本客群將持續擴大，從而在預測期內推動全球無細胞真皮基質市場的成長。例如，2016年，創傷護理和再生醫學公司Acelity LP Inc.在美國推出了再生組織基質「ALLODERM SELECT DUO」。此次上市將使接受雙側乳房重建的美國患者更容易獲得這種組織基質。

本研究的主要特點：

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、區域前景以及主要參與者採取的競爭策略。
本研究根據以下參數介紹了全球無細胞真皮基質市場主要參與者的概況：公司概況、財務表現、產品系列、企業發展區域、分銷策略、主要發展和策略以及未來計劃。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
這份「全球無細胞真皮基質市場」報告旨在為該行業的各種相關人員提供服務，包括投資者、供應商、製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用分析無細胞真皮基質市場中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 日本
- 印度
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

公司簡介
- Integra LifeSciences Corporation
- AbbVie Inc.
- Johnson & Johnson
- HansBioMed
- Becton, Dickinson and Company
- Cook Group
- Smith & Nephew Plc.
- Reprise Biomedical
- Organogenesis Holdings Inc.
- Tissue Regenix
- LifeNet Health
- Zimmer Biomet Holdings, Inc.
- Stryker Corporation
- MiMedx Group
- PolyNovo Limited
- Fidia Pharma USA Inc.
- Baxter International Inc.
- In2Bones Global
- BioHorizons, Inc.
- Harbor MedTech, Inc.
- MLM Biologics Inc.
- Geistlich Pharma AG
- Olaregen Therapeutix, Inc.
- EnColl Corporation
- Kerecis limited
- DSM
- ACell Inc.
- 3M
- Cell Constructs I, LLC
- CG bio Inc.
- Marine Polymer Technologies, Inc.
分析師意見

第9章

調查方法

簡介目錄

Product Code: CMI4362

Acellular Dermal Matrices Market is estimated to be valued at USD 12.41 Bn in 2026 and is expected to reach USD 27.95 Bn by 2033, growing at a compound annual growth rate (CAGR) of 12.3% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 12.41 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	12.30%	2033 Value Projection:	USD 27.95 Bn

Acellular dermal matrices are generated by decellularization process, which leads to the removal of the cells and preserving of the extracellular matrix. The extracellular matrix ones implanted in the required area, serves as the scaffold for the donor cells. The donor cells help in the revascularization, which in turn generates a new tissue.

Market Dynamics:

The increasing prevalence of breast cancer among the women population is expected to increase the rates of masectomy, which in turn is expected to drive growth of the acellular dermal matrices market growth over the forecast period. For instance, in 2019, according to the World Health Organization (WHO), in India, breast cancer accounts for around 2.09 million cases and 627,000 deaths. It is the most common type of cancer in India and accounts for around 14% of all the cancers in women. It has been estimated that, in India, the incidence rate increases in early thirties and are at its peak at the ages 50-64 years.

Increasing availability of the acellular dermal matrices products in different countries is expected to increase the customer base, which in turn will drive the global acellular dermal matrices market growth over the forecast period. For instance, in 2016, Acelity L.P. Inc., a wound care and regenerative medicine company launched ALLODERM SELECT DUO regenerative tissue matrix in the U.S. The launch will increase the availability of the tissue matrix for the U.S. population undergoing bilateral breast reconstruction.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global acellular dermal matrices market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.
Key companies covered as a part of this study include Zimmer Biomet, Stryker Corporation, Staumann, Allergan, Inc., Conmed, Integra LifeSciences Corporation, Aziyo Biologics, Hospital Innovations, Medtronic, Inc., Synthes, Inc., Gunze Corp., Cook Medical Incorporated, C. R. Bard, Inc., and HANS BIOMED CORP.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global acellular dermal matrices market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the acellular dermal matrices market

Detailed Segmentation:

Global Acellular Dermal Matrices Market, By Material Type (Revenue, USD Bn, 2021 - 2033)
Polyhydroxyalkanoate (PHA)
Silicone
Dispersants
Others
Global Acellular Dermal Matrices Market, By Tissue Origin (Revenue, USD Bn, 2021 - 2033)
Human
Porcine
Bovine
Others
Global Acellular Dermal Matrices Market, By Application (Revenue, USD Bn, 2021 - 2033)
Orthopedics
Plastic Surgery
General Surgery
Repair and Replacement of Tissue (Wound Coverage)
Dental
Others
Global Acellular Dermal Matrices Market, By Region (Revenue, USD Bn, 2021 - 2033)
North America
- By Country
  - U.S.
  - Canada
- By Material Type:
  - Polyhydroxyalkanoate (PHA)
  - Silicone
  - Dispersants
  - Others
- By Tissue Origin
  - Human
  - Porcine
  - Bovine
  - Others
- By Application
  - Orthopedics
  - Plastic Surgery
  - General Surgery
  - Repair and Replacement of Tissue (Wound Coverage)
  - Dental
  - Others
  - Latin America
- By Country:
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- By Material Type:
  - Polyhydroxyalkanoate (PHA)
  - Silicone
  - Dispersants
  - Others
- By Tissue Origin
  - Human
  - Porcine
  - Bovine
  - Others
- By Application
  - Orthopedics
  - Plastic Surgery
  - General Surgery
  - Repair and Replacement of Tissue (Wound Coverage)
  - Dental
  - Others
Europe
- By Country:
  - U.K.
  - Germany
  - Italy
  - Spain
  - France
  - Russia
  - Rest of Europe
- By Material Type:
  - Polyhydroxyalkanoate (PHA)
  - Silicone
  - Dispersants
  - Others
- By Tissue Origin
  - Human
  - Porcine
  - Bovine
  - Others
- By Application
  - Orthopedics
  - Plastic Surgery
  - General Surgery
  - Repair and Replacement of Tissue (Wound Coverage)
  - Dental
  - Others
Asia Pacific
- By Country:
  - Australia
  - India
  - China
  - Japan
  - ASEAN
  - South Korea
  - Rest of Asia Pacific
- By Material Type:
  - Polyhydroxyalkanoate (PHA)
  - Silicone
  - Dispersants
  - Others
- By Tissue Origin
  - Human
  - Porcine
  - Bovine
  - Others
- By Application
  - Orthopedics
  - Plastic Surgery
  - General Surgery
  - Repair and Replacement of Tissue (Wound Coverage)
  - Dental
  - Others
Middle East
- By Country:
  - GCC
  - Israel
  - Rest of Middle East
- By Material Type:
  - Polyhydroxyalkanoate (PHA)
  - Silicone
  - Dispersants
  - Others
- By Tissue Origin
  - Human
  - Porcine
  - Bovine
  - Others
- By Application
  - Orthopedics
  - Plastic Surgery
  - General Surgery
  - Repair and Replacement of Tissue (Wound Coverage)
  - Dental
  - Others
Africa
- By Country/Region:
  - South Africa
  - Central Africa
  - North Africa
- By Material Type:
  - Polyhydroxyalkanoate (PHA)
  - Silicone
  - Dispersants
  - Others
- By Tissue Origin
  - Human
  - Porcine
  - Bovine
  - Others
- By Application
  - Orthopedics
  - Plastic Surgery
  - General Surgery
  - Repair and Replacement of Tissue (Wound Coverage)
  - Dental
  - Others
Company Profiles
Zimmer Biomet*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
Stryker Corporation
Staumann, Allergan, Inc.
Conmed
Integra LifeSciences Corporation
Aziyo Biologics
Hospital Innovations
Medtronic, Inc.
Synthes, Inc.
Gunze Corp.
Cook Medical Incorporated
R. Bard, Inc.
HANS BIOMED CORP.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Origin
- Market Snippet, By Application
- Market Snippet, By Place of Setting
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Recent Trend
Key Developments
Regulatory Scenario
PEST Analysis
PORTER's Analysis
Product Launches/Approvals Mergers, Acquisitions and Collaborations

4. Global Acellular Dermal Matrices Market, By Origin, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Human Dermis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Porcine Dermis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
Bovine Dermis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)

5. Global Acellular Dermal Matrices Market, By Application, 2021-2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Acute Wounds
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
  - Burns
  - Trauma
  - Cancers
  - Infections
Chronic Wounds
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
  - Diabetic Foot Ulcers
  - Venous Leg Ulcers
  - Pressure Ulcer
  - Others
Reconstruction Procedures
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
  - Abdominal Wall Procedures
  - Breast Procedures
  - Orthopedic Procedures
  - Others

6. Global Acellular Dermal Matrices Market, By Place of Setting, 2021-2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
  - In- patient
  - Out- patient
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
Office Based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)

7. Global Acellular Dermal Matrices Market, By Region, 2021-2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Place of Setting, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 -2033, (US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Place of Setting, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 -2033, (US$ Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Place of Setting, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 -2033, (US$ Bn)
  - China
  - Japan
  - India
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Place of Setting, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 -2033, (US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Place of Setting, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 -2033, (US$ Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Origin, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Place of Setting, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 -2033, (US$ Bn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Company Profiles
- Integra LifeSciences Corporation
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- AbbVie Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Johnson & Johnson
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- HansBioMed
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Becton, Dickinson and Company
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Cook Group
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Smith & Nephew Plc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Reprise Biomedical
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Organogenesis Holdings Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Tissue Regenix
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- LifeNet Health
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Zimmer Biomet Holdings, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Stryker Corporation
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- MiMedx Group
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- PolyNovo Limited
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Fidia Pharma USA Inc.
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Baxter International Inc.
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- In2Bones Global
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- BioHorizons, Inc.
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Harbor MedTech, Inc.
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- MLM Biologics Inc.
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Geistlich Pharma AG
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Olaregen Therapeutix, Inc.
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- EnColl Corporation
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Kerecis limited
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- DSM
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- ACell Inc.
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- 3M
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Cell Constructs I, LLC
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- CG bio Inc.
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Marine Polymer Technologies, Inc.
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
Analysts' Views